Meghmani Organics Limited (MOL) Fair Value & Analysis
Basic Materials · IN · Market cap ₹12.1B
Fair value as of: Jul 3, 2026
From 25 valuation models · updated today
Share price −2.3% over the past month.
Price vs Fair Value (12 months)
12‑month range ₹36.60 – ₹101.41 · fair‑value band ₹14.41 – ₹24.01 · the ₹47.46 price screens above the ₹19.21 fair value. As of Jul 3, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Meghmani Organics Limited (MOL) currently trades at ₹47.46, while our model-based Fair Value estimate is ₹19.21 — implying the stock looks roughly 59.5% overvalued today. We read business quality at 50/100 (solid quality), in the Basic Materials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).
Over the trailing twelve months, Meghmani Organics Limited generated revenue of ₹21.7B at a net margin of 1.3%. Revenue declined 14.3% year over year. It earns a return on equity of 1.9%. Net debt stands at ₹7.0B. Fundamentals as of Jul 3, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 3, 2026. TTM = trailing twelve months.
About the company
Meghmani Organics Limited manufactures and sells pigments and agrochemicals in India and internationally. The company offers green and blue pigments, which are used in printing inks, paints and coatings, and plastics. It also offers agrochemical products comprising insecticides, which include acetamiprid, alphacypermethrin, bifenthrin, betacyfluthrin, cyfluthrin, cypermethrin, deltamethrin, dinotefuran, ethiprole, fipronil, flonicamid, flubendiamide, lambdacyhalothrin, permethrin, profenofos, pymetrozine, pyriproxyfen, and spiromesifen. in addition, the company provides herbicides, such as 2,4 D acid, amine, esters and triclopyr; intermediates, including cypermethric acid chloride, lambdacyhalothric acid (TFP Acid), pyrazole, high cis/trans CMAC, meta phenoxy benzaldehyde, and spiromesifen acid. Further, it offers technical and formulations that are used in crop protection, veterinary health, household pest control, and public health initiatives. Additionally, the company offers …
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Meghmani Organics Limited reported revenue of ₹21.7B in FY2025 versus ₹24.7B in FY2021, a compound −3.2%/yr. Reported net income was ₹287M in FY2025, compounding −44.6%/yr from FY2021.
Is MOL fairly valued? → Check now
Similar stocks
6 more Agricultural Inputs stocks, each showing price versus our Fair Value estimate (as of Jul 3, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Corteva, Inc CTVA | $74.46 | $37.84 | -49% |
| Nutrien Ltd NTR | $62.25 | $80.29 | +29% |
| Qinghai Salt Lake Industry Co 000792 | ¥29.45 | ¥21.15 | -28% |
| CF Industries Holdings C1FI34 | R$533.71 | R$176.57 | -67% |
| Yara International ASA YAR | kr 469.90 | kr 875.16 | +86% |
| ICL Group ICL | $5.50 | $3.44 | -37% |
Explore undervalued stocks
More undervalued Basic Materials stocks →
Frequently asked questions
Is Meghmani Organics Limited (MOL) undervalued?
What is the fair value of MOL?
What is the quality score of MOL?
What is the revenue of Meghmani Organics Limited (MOL)?
What is the net profit margin of MOL?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.